Oragenics' IPO

Oragenics raised a round of funding on December 16, 2008. Investors include Public.

Oragenics, formerly ONI Biopharma, is a publicly-traded biopharmaceutical company with a pipeline of technologies and a primary focus on commercialization. The corporate strategy is to bring products…

Articles about Oragenics' IPO: